Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-142071

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 15, 2016
Accepted (ET)
Sep 19, 2016 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 15, 2016J521,739$0.00D0IBy NeXeption, LLC
Common StockSep 15, 2016J116,999$0.00A116,999D
Common StockF2Sep 15, 2016J144,153$0.00A144,153IBy NST, LLC
Common StockF2Sep 15, 2016J50,002$0.00D94,151IBy NST, LLC
Common StockSep 15, 2016J4,790$0.00A121,789D
Common StockF4holding———394,014IBy Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses